Drugs / GreenGene
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01568580 | Dec 2004 → Sep 2006 | hemophilia A | Green Cross Corporation | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GreenGene | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01568580 ↗ |
| Known as | Recombinant Factor VIII | “Efficacy and Safety of Recombinant Factor VIII (GreenGene) in Patients With Hemophilia A” NCT01568580 ↗ |
| Modality | Protein / enzyme biologic | “Recombinant Factor VIII” NCT01568580 ↗ |
| Route | Intravenous | “intravenous infusion” NCT01568580 ↗ |